Already on ArticleSlash?

Forgot your password? Sign Up

New Drug May Increase Breast Cancer Survival


Visitors: 179

New research shows that a new drug called an aromatase inhibitor may boost the survival rate of post menopausal women who suffer from breast cancer. It has show to be a good improvement over the current tamoxifen therapy.

The Italian study switched women taking the tamoxifen therapy to the aromatase inhibitor 2 to 3 years into the normal 5 year regiment. According to the results, there was improved performance of the aromatase inhibitors. This means that not only is it more efficient at fighting cancer, it will also allow users to avoid the adverse side affects such as endometrial cancer and strokes created by the other medication

Dr. Gary M. Freedman, a radiation oncologist at the Fox Chase Cancer Center in Philadelphia said, "There's still a lot of questions that remain, but this study confirms that five years of tamoxifen alone is really becoming the wrong answer for most postmenopausal women. At this point, you have to say that aromatase inhibitors are in the mix of treatment at some point. "

According the HealthDay News, Tamoxifen has been in widespread use among breast cancer survivors for the last two decades. The drug is typically taken after surgery, because it targets the hormone estrogen, which can promote tumor cell growth in women with estrogen-sensitive breast cancer. A standard five-year treatment of tamoxifen has been found to reduce breast cancer death rates by as much as 31 percent.

Tamoxifen must still undergo many tests and trials before it will even be considered for approval. But it is definitely a step in the right direction not to just find a new better cure, but to also realize where our current treatments fall short.

Click here for more information on ordering online prescriptions from discount pharmacies.

Joshua Daly is the author of many health related articles as well as the President of Joshua's goal is to help consumers save money and make better informed decisions. Click here for more information on ordering from a discount online pharmacy .


Article Source:

Rate this Article: 
HER2-positive breast cancer and targeted drug Herceptin
Rated 4 / 5
based on 5 votes

Related Articles:

Breast Cancer Survival Rate - Stage 4 Breast Cancer

by: Sharon A Jones (August 24, 2007) 
(Cancer/Breast Cancer)

Breast Cancer Survival Clues

by: Stephan Grindley (September 23, 2008) 
(Cancer/Breast Cancer)

Breast Cancer Survival Rate

by: Nathalie Fiset (November 27, 2007) 
(Cancer/Breast Cancer)

Low Fat Diet May Improve Survival in Breast Cancer

by: Steven Vasilev MD (February 09, 2007) 

Survival Rates Of Breast Cancer At Different Stages

by: Moses Wright (March 21, 2008) 
(Cancer/Breast Cancer)

Mammography Increases The Survival Rate Of Breast Cancer Patients

by: Kason Mou (June 10, 2011) 
(Health and Fitness/Diseases)

Increasing Your Chance Of Survival By Recognizing Breast Cancer Symptoms

by: Riley Hendersen (March 30, 2007) 

Digital Mammography Images increases the survival rate of breast cancer patients

by: Kason Mou (June 06, 2011) 
(Health and Fitness/Diseases)

New Drug Aromasin May Reduce Breast Cancer Risks

by: Fower Lee (July 20, 2011) 
(Health and Fitness/Diseases)

HER2-positive breast cancer and targeted drug Herceptin

by: Kason Mou (August 16, 2011) 
(Health and Fitness/Diseases)